诺和诺德CEO因股价低迷被解雇,司美格鲁肽全球畅销难挽颓势

DoNews
18 May

5月16日,欧洲药企巨头诺和诺德宣布现任CEO周赋德将离任。尽管其主导的减肥药司美格鲁肽全球热销,但因市场竞争加剧及下一代药物试验不佳,公司股价较去年高点跌超50%,市值蒸发超3600亿美元。周赋德年薪曾超5000万元人民币,他表示对离职决定感到意外。诺和诺德称此举符合公司与股东最佳利益,新任CEO正在遴选中。免责声明:本文内容由开放的智能模型自动生成,仅供参考。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10